BIOMOTION PHARMA ApS: Financial statements 2021
CVR: 12928203
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,250 and a net result of DKK 3,750 compared with DKK -1,250 the year before. Equity in the 2021 report amounted to DKK 5,000. The solvency ratio was 80%.
- Gross Profit
- DKK -1,250
- Profit/Loss
- DKK 3,750
- Equity
- DKK 5,000
- Total Assets
- DKK 6,250
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -1 t. | 4 t. | 5 t. | - |
| 2020 | - | -1 t. | -1 t. | 1 t. | - |
| 2019 | - | -2 t. | -2 t. | 3 t. | - |
| 2018 | - | 5 t. | 5 t. | 4 t. | - |
| 2017 | - | - | 0 | -999 | - |
Official annual report
Find more companies like BIOMOTION PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company is in liquidation. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Michael Rasmussen. The company is owned by Michael Rasmussen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,000 and a net result of DKK -4,202 compared with DKK -6,460 the year before. Equity in the 2025 report amounted to DKK -892.